Studies on in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice
Studies on in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice
批准号:
12558097
负责人:
OHNISHI Yasuyuki
金额:
$8.45万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
我们研究了利用致癌基因工程小鼠建立肿瘤预防和进展治疗的体内评价系统。我们一直在研究利用携带人类原型H-ras癌基因的rasH2转基因小鼠进行致癌性测试的模型。在这项研究中,我们建立了乌拉坦诱导的肺癌模型,致瘤性非常快。我们将这种易患癌症的小鼠系统应用于评估用于癌症预防或预防癌症进展的药物或治疗方案,如化学预防。rasH2小鼠被注射乌拉坦诱发肺癌。在乌拉坦注射后或注射前,将IL-6相关基因复合体(IL-6、IL-6受体和gp130)攻击小鼠。在乌拉坦和氨基甲酸乙烯酯(Vc,乌拉坦的近端致癌物)诱发的小鼠肺肿瘤中,导入人H-ras基因的突变分析表明,IL-6相关基因复合体具有化学预防作用。结果表明,几乎所有肿瘤都存在H-ras基因第61位密码子突变。这些结果表明,转基因61位密码子的点突变在VC和氨基甲酸乙酯诱发的rasH2小鼠肺癌的发生中起重要作用。
英文摘要
We studied to establish in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice. We have been studying carcinogenicity testing model using rasH2 transgenic mice harboring human prototype H-ras oncogene. In this study, we established urethane-induced lung cancer model with very rapid tumorigenicity. We applied this cancer prone mice system for evaluation of drug or treatment protocol for cancer protection or prevention of cancer progression such as chemoprevention.The rasH2 mice were injected urethane to induce lung tumor. After or before urethane injection, IL-6 related gene complex (IL-6, IL-6 receptor and gp130) was challenged into the mice. The incidence of lung tumor formation in the urethane injected rasH2 mice was clearly reduced, meaning the IL-6 related gene complex has chemoprevention effects.The mutational analyses of introducing human H-ras were performed in the lung tumor which induced by urethane and vinylcarbamate (VC, proximal carcinogen of urethane). The results showed almost all tumors had mutation at the 61st codon of H-ras. These results suggested that point mutations at codon 61 of the transgene play an important role in the carcinogenesis of VC- and urethane- induced lung tumors in rasH2 mice.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Maruyama, C: "Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice"Oncol.Rep.. 8. 233-237 (2001)
Maruyama, C:“人类 H-ras 转基因的过度表达是导致小鼠化学致癌物诱发肿瘤的原因”Oncol.Rep.. 8. 233-237 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Birumachi, J.: "Diesel exhaust-induced airway hyperresponsiveness in c-Ha-ras transgenic mice"Toxicology. 163. 145-152 (2001)
Birumachi, J.:“柴油机尾气引起 c-Ha-ras 转基因小鼠气道高反应性”毒理学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zembutsu H.: "Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs."Cancer Res.. 62. 518-527 (2002)
Zembutsu H.:“全基因组 cDNA 微阵列筛选,将基因表达谱与 85 个人类癌症异种移植物对抗癌药物的敏感性相关联。”Cancer Res.. 62. 518-527 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chulan, S.a: "Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines"Oncol. Rep.. 58. 89-92 (2001)
Chulan, S.a:“15 种人类胰腺癌细胞系中 K-ras、p53、p16 和 SMAD4 基因突变的特征”Oncol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohnishi, Y.: "Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgenic mice carrieng human prototype c-Ha-ras gene and their wild type littermates"Exp.Anim.. 50. 33-39 (2001)
Ohnishi, Y.:“在携带人类原型 c-Ha-ras 基因的转基因小鼠及其野生型同窝小鼠中通过甲基胆蒽和苯巴比妥诱导药物代谢相关酶”Exp.Anim.. 50. 33-39 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
Establishment of human tumor xenotransplantation models as a pre-clinical assisting tool for translational research
-
批准号:13480283
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.26万
-
财政年份:2001
-
负责人:OHNISHI Yasuyuki
-
依托单位:
Knock-down mouse, a novel gene engineering mouse for use as a disease model
-
批准号:11480251
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$9.41万
-
财政年份:1999
-
负责人:OHNISHI Yasuyuki
-
依托单位:
Improvement of human tumor xenograft-mouse model as a preclinical evaluation system of new drugs discovered and developed by the novel strategy against cancer
-
批准号:08458278
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$1.73万
-
财政年份:1996
-
负责人:OHNISHI Yasuyuki
-
依托单位:
A new approach for prediction of clinical efficacy of anticancer drugs based on toxicokinetic and pharmacokinetic analysis
-
批准号:07558117
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$5.31万
-
财政年份:1995
-
负责人:OHNISHI Yasuyuki
-
依托单位:
Studies on genetic and microbiologicail quality of human tumor xenografts lines as a tool for animal experiments
-
批准号:05454690
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.52万
-
财政年份:1993
-
负责人:OHNISHI Yasuyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
-
批准号:2026JJ81631
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖思思
-
依托单位:
七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
-
批准号:JCZRLH202601296
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
-
批准号:JCZRLH202600985
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
-
批准号:JCZRLH202601410
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于"热证可灸"理论的中药联合铺棉灸治疗带状疱疹急性期的临床疗效及对血清SP、β-EP、IL-6、IL-10、NSE水平的影响
-
批准号:2026JJ81075
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄迎春
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于IL-6/STAT3通路巨噬细胞极化调控免疫反应在胸膜结核瘤形成中的机制
-
批准号:2026JJ82516
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张锋
-
依托单位:
基于“截断扭转”学说探讨凉膈散通过IL-6/STAT3/RORγt轴调控脓毒症Th17/Treg稳态的机制及临床研究
-
批准号:2026JJ82600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄磊
-
依托单位:
从肝失疏泄探讨肝脏代谢物介导IL-6/STAT3通路调控GABA能系统对睡眠节律影响的机制及逍遥散的干预作用
-
批准号:2026JJ30175
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:滕永杰
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: